Free Shipping on purchases over €100

Nicorette® Supermint 4 mg , 40 tablets
Nicorette® Supermint 4 mg , 40 tablets
New packaging Nicorette® Supermint 4 mg , 40 tablets
Relief from the urge to smoke

Nicorette® Supermint 4 mg , 40 tablets

Nicorette® Supermint 4 mg sucking tablets, 40 tablets for adults, relieves the symptoms of those who are trying to quit smoking.

SKU: NI8470007648796
-5%
23.23
€24.45

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Nicorette® Supermint 4 mg, nicotine lozenges, is used to relieve withdrawal symptoms and reduce nicotine cravings that occur when trying to quit smoking. This treatment is indicated for adult smokers over 18 years of age who smoke more than 20 cigarettes a day or who are highly dependent on nicotine.

Nicorette® Supermint 4 mg lozenge is suitable for smokers who have a high nicotine dependence, for example, those who smoke their first cigarette of the day within 30 minutes of waking up or those who smoke more than 20 cigarettes a day.

Nicorette® Supermint relieves nicotine withdrawal symptoms, including cravings, associated with smoking cessation. When you suddenly stop providing your body with nicotine from tobacco, you are affected by different types of unpleasant feelings, known as withdrawal symptoms, such as irritability or aggressiveness, depression, anxiety, restlessness, concentration problems, increased appetite or weight gain, cravings (anxiety), night-time awakenings or sleep disorders.

The nicotine in Nicorette® Supermint can help prevent or reduce these unpleasant symptoms, as well as your cravings. To improve your chances of getting help to quit smoking, it is advisable to seek medical advice and support.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.